{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T15:43:37Z","timestamp":1793029417094,"version":"4.5.0"},"reference-count":40,"publisher":"Bioscientifica","issue":"10","license":[{"start":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T00:00:00Z","timestamp":1791763200000},"content-version":"vor","delay-in-days":11,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["journals.bioscientifica.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,10,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>Hypoglycemia is common in patients with adrenal insufficiency (AI), who require lifelong glucocorticoid replacement therapy. However, whether this therapy restores physiological glycemic fluctuations in patients with AI remains unclear. This study aimed to characterize glucose fluctuation pattern in patients with AI using continuous glucose monitoring (CGM).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Twenty-seven patients with AI on stable doses of glucocorticoid were consecutively enrolled. Fifty-four age-, sex-, and BMI-matched normal controls (NCs) were selected from a healthy volunteer database at a 2:1 ratio. CGM was conducted with a blinded method for 14 days. Glucocorticoid regimen and adverse events during CGM were documented.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The AI group had a mean age of 59.53 \u00b1 8.51 years (15 males). Compared with NCs, patients with AI exhibited increased time below range (TBR, glucose &amp;lt;3.9 and &amp;lt;3.0 mmol\/L) and decreased time in range (TIR, glucose within 3.9\u20137.8 mmol\/L). Time above range (TAR, glucose \u2265 7.8 mmol\/L) was elevated during the lunch and dinner periods, and glucose fluctuation parameters were also increased. CGM-detected hypoglycemia was observed in all patients (27\/27, 100%) versus 46\/54 (85.2%) controls (P = 0.047). Patients receiving once-daily glucocorticoid had higher lunchtime TAR than those on twice-daily dosing. Hydrocortisone-treated patients showed higher breakfast and lunchtime TAR compared with prednisone users. Patients with immune checkpoint inhibitor (ICI)-induced AI had higher glucose levels and fluctuation parameters during breakfast and dinner periods than those with other etiologies.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Patients with AI receiving glucocorticoid replacement experience more frequent CGM-recorded asymptomatic hypoglycemia and greater glucose variability. CGM may provide valuable insights for optimizing glucocorticoid administration strategies in AI.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1530\/ec-26-0304","type":"journal-article","created":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T18:17:52Z","timestamp":1791829072000},"update-policy":"https:\/\/doi.org\/10.1530\/crossmarkpolicy-10","source":"Crossref","is-referenced-by-count":0,"title":["Continuous glucose monitoring reveals glycemic profile in adrenal insufficiency patients on glucocorticoid replacement"],"prefix":"10.1530","volume":"15","author":[{"given":"Cuili","family":"Ning","sequence":"first","affiliation":[{"name":"Department of Endocrinology, Shijiazhuang Second Hospital 1 , ,","place":["Shijiazhuang, China"]},{"name":"Department of Endocrinology, Peking University People\u2019s Hospital 2 , ,","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Peking University People\u2019s Hospital 2 , ,","place":["Beijing, China"]},{"name":"Peking University Diabetes Center 3 , ,","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Peking University People\u2019s Hospital 2 , ,","place":["Beijing, China"]},{"name":"Peking University Diabetes Center 3 , ,","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianghai","family":"Zhou","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Peking University People\u2019s Hospital 2 , ,","place":["Beijing, China"]},{"name":"Peking University Diabetes Center 3 , ,","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunyang","family":"Sun","sequence":"additional","affiliation":[{"name":"Shanghai iMedpower Tech.LTD 4 , ,","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5450-5563","authenticated-orcid":true,"given":"Xueyao","family":"Han","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Peking University People\u2019s Hospital 2 , ,","place":["Beijing, China"]},{"name":"Peking University Diabetes Center 3 , ,","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3262-2168","authenticated-orcid":true,"given":"Linong","family":"Ji","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Peking University People\u2019s Hospital 2 , ,","place":["Beijing, China"]},{"name":"Peking University Diabetes Center 3 , ,","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5729-8264","authenticated-orcid":true,"given":"Qian","family":"Ren","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Peking University People\u2019s Hospital 2 , ,","place":["Beijing, China"]},{"name":"Peking University Diabetes Center 3 , ,","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"416","published-online":{"date-parts":[[2026,10,12]]},"reference":[{"key":"2026102611315182700_bib1","doi-asserted-by":"crossref","first-page":"115","DOI":"10.7861\/clinmed.2023-0067","article-title":"Diagnosis and management of adrenal insufficiency","volume":"23","author":"Lewis","year":"2023","journal-title":"Clin Med"},{"key":"2026102611315182700_bib2","doi-asserted-by":"crossref","first-page":"G25","DOI":"10.1093\/ejendo\/lvae029","article-title":"European Society of Endocrinology and Endocrine Society Joint Clinical Guideline: diagnosis and therapy of glucocorticoid-induced adrenal insufficiency","volume":"190","author":"Beuschlein","year":"2024","journal-title":"Eur J Endocrinol"},{"key":"2026102611315182700_bib3","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1053\/j.seminoncol.2023.11.003","article-title":"Primary adrenal insufficiency induced by immune checkpoint inhibitors: biological, clinical, and radiological aspects","volume":"50","author":"Martella","year":"2023","journal-title":"Semin Oncol"},{"key":"2026102611315182700_bib4","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/cen.12603","article-title":"Adrenal insufficiency: review of clinical outcomes with current glucocorticoid replacement therapy","volume":"82","author":"Johannsson","year":"2015","journal-title":"Clin Endocrinol"},{"key":"2026102611315182700_bib5","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1001\/jama.2025.5485","article-title":"Adrenal insufficiency in adults: a review","volume":"334","author":"Vaidya","year":"2025","journal-title":"JAMA"},{"key":"2026102611315182700_bib6","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1007\/BF03345773","article-title":"Metabolic and cardiovascular profile in patients with Addison\u2019s disease under conventional glucocorticoid replacement","volume":"32","author":"Giordano","year":"2009","journal-title":"J Endocrinol Investig"},{"key":"2026102611315182700_bib7","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1530\/EJE-07-0455","article-title":"Glucocorticoids and cardiovascular disease","volume":"157","author":"Walker","year":"2007","journal-title":"Eur J Endocrinol"},{"key":"2026102611315182700_bib8","doi-asserted-by":"crossref","first-page":"R231","DOI":"10.1530\/EJE-17-0154","article-title":"Management of endocrine disease: risk of overtreatment in patients with adrenal insufficiency: current and emerging aspects","volume":"177","author":"Mazziotti","year":"2017","journal-title":"Eur J Endocrinol"},{"key":"2026102611315182700_bib9","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1530\/EJE-08-0874","article-title":"Inadequacies of glucocorticoid replacement and improvements by physiological circadian therapy","volume":"160","author":"Debono","year":"2009","journal-title":"Eur J Endocrinol"},{"key":"2026102611315182700_bib10","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/S2213-8587(22)00319-9","article-title":"Continuous glucose monitoring and metrics for clinical trials: an international consensus statement","volume":"11","author":"Battelino","year":"2023","journal-title":"Lancet Diabetes Endocrinol"},{"key":"2026102611315182700_bib11","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.4239\/wjd.v14.i7.1112","article-title":"Glucose metabolism profile recorded by flash glucose monitoring system in patients with hypopituitarism during prednisone replacement","volume":"14","author":"Han","year":"2023","journal-title":"World J Diabetes"},{"key":"2026102611315182700_bib12","article-title":"Impact of glucocorticoid replacement therapy on nocturnal hypoglycemia in adrenal insufficiency: an analysis of multiple case studies","volume":"16","author":"Kanazawa","year":"2024","journal-title":"Cureus"},{"key":"2026102611315182700_bib13","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/s40618-025-02728-9","article-title":"Hypoglycaemia and other risks of ramadan fasting in patients with primary adrenal insufficiency: a prospective controlled trial using 24-hour glucose monitoring","volume":"49","author":"Chihaoui","year":"2026","journal-title":"J Endocrinol Investig"},{"key":"2026102611315182700_bib14","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.nut.2017.07.014","article-title":"The risk for hypoglycemia during Ramadan fasting in patients with adrenal insufficiency","volume":"45","author":"Chihaoui","year":"2018","journal-title":"Nutrition"},{"key":"2026102611315182700_bib15","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1210\/clinem\/dgae250","article-title":"European Society of Endocrinology and Endocrine Society joint clinical guideline: diagnosis and therapy of glucocorticoid-induced adrenal insufficiency","volume":"109","author":"Beuschlein","year":"2024","journal-title":"J Clin Endocrinol Metab"},{"key":"2026102611315182700_bib16","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1177\/1932296816662884","article-title":"A multicenter evaluation of the performance and usability of a novel glucose monitoring system in Chinese adults with diabetes","volume":"11","author":"Ji","year":"2017","journal-title":"J Diabetes Sci Technol"},{"key":"2026102611315182700_bib17","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1007\/s13410-022-01112-0","article-title":"Evaluation of the performance and usability of a novel continuous glucose monitoring system","volume":"43","author":"Yan","year":"2023","journal-title":"Int J Diabetes Dev Ctries"},{"key":"2026102611315182700_bib18","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1507\/endocrj.EJ16-0387","article-title":"Usage of continuous glucose monitoring (CGM) for detecting an unrecognized hypoglycemia and management of glucocorticoid replacement therapy in adult patients with central hypoadrenalism","volume":"65","author":"Watanabe","year":"2018","journal-title":"Endocr J"},{"key":"2026102611315182700_bib19","doi-asserted-by":"crossref","first-page":"K19","DOI":"10.1093\/ejendo\/lvad147","article-title":"Glucose pattern in children with classical congenital adrenal hyperplasia: evidence from continuous glucose monitoring","volume":"189","author":"Galderisi","year":"2023","journal-title":"Eur J Endocrinol"},{"key":"2026102611315182700_bib20","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1111\/cen.12123","article-title":"Nocturnal hypoglycaemia in ACTH and GH deficient children: role of continuous glucose monitoring","volume":"79","author":"Cambiaso","year":"2013","journal-title":"Clin Endocrinol"},{"key":"2026102611315182700_bib21","doi-asserted-by":"crossref","DOI":"10.1210\/jendso\/bvac119","article-title":"Frequency of adrenal insufficiency in patients with hypoglycemia in an emergency department: a cross-sectional study","volume":"6","author":"Kawahara","year":"2022","journal-title":"J Endocr Soc"},{"key":"2026102611315182700_bib22","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1210\/endrev\/bnae024","article-title":"The cortisol awakening response: regulation and functional significance","volume":"46","author":"Stalder","year":"2025","journal-title":"Endocr Rev"},{"key":"2026102611315182700_bib23","doi-asserted-by":"crossref","first-page":"3553","DOI":"10.1210\/jc.2007-0445","article-title":"Effects of cortisol on carbohydrate, lipid, and protein metabolism: studies of acute cortisol withdrawal in adrenocortical failure","volume":"92","author":"Christiansen","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"2026102611315182700_bib24","doi-asserted-by":"crossref","first-page":"R49","DOI":"10.1530\/JOE-14-0373","article-title":"Glucocorticoid treatment and endocrine pancreas function: implications for glucose homeostasis, insulin resistance and diabetes","volume":"223","author":"Rafacho","year":"2014","journal-title":"J Endocrinol"},{"key":"2026102611315182700_bib25","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1111\/j.1365-2265.2004.02106.x","article-title":"Weight-related dosing, timing and monitoring hydrocortisone replacement therapy in patients with adrenal insufficiency","volume":"61","author":"Mah","year":"2004","journal-title":"Clin Endocrinol"},{"key":"2026102611315182700_bib26","doi-asserted-by":"crossref","first-page":"2881","DOI":"10.1111\/dom.15608","article-title":"Continuous glucose monitoring for glycaemic control and cardiovascular risk reduction in patients with type 2 diabetes not on insulin therapy: a clinical trial","volume":"26","author":"Reed","year":"2024","journal-title":"Diabetes Obes Metab"},{"key":"2026102611315182700_bib27","doi-asserted-by":"crossref","first-page":"2154","DOI":"10.1111\/dom.16212","article-title":"Impact of time in tight range on all-cause and cardiovascular mortality in type 2 diabetes: a prospective cohort study","volume":"27","author":"Cai","year":"2025","journal-title":"Diabetes Obes Metab"},{"key":"2026102611315182700_bib28","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1472-6823-12-8","article-title":"Current practice of glucocorticoid replacement therapy and patient-perceived health outcomes in adrenal insufficiency \u2013 a worldwide patient survey","volume":"12","author":"Forss","year":"2012","journal-title":"BMC Endocr Disord"},{"key":"2026102611315182700_bib29","doi-asserted-by":"crossref","DOI":"10.1530\/EC-23-0097","article-title":"Optimising prednisolone or prednisone replacement in adrenal insufficiency","volume":"12","author":"Sharma","year":"2023","journal-title":"Endocr Connect"},{"key":"2026102611315182700_bib30","doi-asserted-by":"crossref","first-page":"434","DOI":"10.3389\/fendo.2018.00434","article-title":"Glycometabolic alterations in secondary adrenal insufficiency: does replacement therapy play a role?","volume":"9","author":"Graziadio","year":"2018","journal-title":"Front Endocrinol"},{"key":"2026102611315182700_bib31","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1210\/jc.2011-1926","article-title":"Improved cortisol exposure-time profile and outcome in patients with adrenal insufficiency: a prospective randomized trial of a novel hydrocortisone dual-release formulation","volume":"97","author":"Johannsson","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"2026102611315182700_bib32","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1530\/EJE-14-1114","article-title":"Modified-release hydrocortisone decreases BMI and HbA1c in patients with primary and secondary adrenal insufficiency","volume":"172","author":"Quinkler","year":"2015","journal-title":"Eur J Endocrinol"},{"key":"2026102611315182700_bib33","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1210\/jc.2013-4253","article-title":"Continuous subcutaneous hydrocortisone infusion versus oral hydrocortisone replacement for treatment of Addison\u2019S disease: a randomized clinical trial","volume":"99","author":"Oksnes","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"2026102611315182700_bib34","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1111\/j.1365-2265.2009.03636.x","article-title":"A pharmacokinetic and pharmacodynamic study of delayed- and extended-release hydrocortisone (Chronocort) vs. conventional hydrocortisone (Cortef) in the treatment of congenital adrenal hyperplasia","volume":"72","author":"Verma","year":"2010","journal-title":"Clin Endocrinol"},{"key":"2026102611315182700_bib35","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1038\/s41598-022-04904-w","article-title":"Prediction of diabetes mellitus induced by steroid overtreatment in adrenal insufficiency","volume":"12","author":"Guarnotta","year":"2022","journal-title":"Sci Rep"},{"key":"2026102611315182700_bib36","doi-asserted-by":"crossref","first-page":"4849","DOI":"10.1210\/jc.2006-0076","article-title":"Premature mortality in patients with Addison\u2019s disease: a population-based study","volume":"91","author":"Bergthorsdottir","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"2026102611315182700_bib37","doi-asserted-by":"crossref","first-page":"3954","DOI":"10.1210\/jc.2006-0524","article-title":"The impact of glucocorticoid replacement regimens on metabolic outcome and comorbidity in hypopituitary patients","volume":"91","author":"Filipsson","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"2026102611315182700_bib38","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1210\/jc.2011-2036","article-title":"Bone mineral density is not significantly reduced in adult patients on low-dose glucocorticoid replacement therapy","volume":"97","author":"Koetz","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"2026102611315182700_bib39","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1530\/EJE-14-0397","article-title":"The relationship between glucocorticoid replacement and quality of life in 2737 hypopituitary patients","volume":"171","author":"Ragnarsson","year":"2014","journal-title":"Eur J Endocrinol"},{"key":"2026102611315182700_bib40","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1038\/s41571-019-0218-0","article-title":"Adverse effects of immune-checkpoint inhibitors: epidemiology, management and surveillance","volume":"16","author":"Martins","year":"2019","journal-title":"Nat Rev Clin Oncol"}],"container-title":["Endocrine Connections"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.bioscientifica.com\/ec\/article-pdf\/doi\/10.1530\/EC-26-0304\/526423\/ec-26-0304.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/journals.bioscientifica.com\/ec\/article-pdf\/doi\/10.1530\/EC-26-0304\/526423\/ec-26-0304.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T15:32:00Z","timestamp":1793028720000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.bioscientifica.com\/ec\/article\/15\/10\/e260304\/78364\/Continuous-glucose-monitoring-reveals-glycemic"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,1]]},"references-count":40,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10,1]]}},"URL":"https:\/\/doi.org\/10.1530\/ec-26-0304","relation":{},"ISSN":["2049-3614"],"issn-type":[{"value":"2049-3614","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,1]]},"article-number":"e260304"}}